In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Acadia Pharmaceuticals Inc.

Latest From Acadia Pharmaceuticals Inc.

Finance Watch: Two New IPOs – IGM In the US, Henlius In Hong Kong – Gross Nearly $600m

Public Company Edition: IGM raised $175m to advance its IgM antibodies and Henlius brought in $410m for its novel drug and biosimilar platforms. Also, Acadia follow-on brings in $250m, PTC sells $350m worth of stock and debt, and Karyopharm royalty deal totals $150m.

Financing Business Strategies

Acadia Claims Success For Nuplazid In A Broader Psychosis Indication

The company expects to file pimavanserin for the treatment of dementia-related psychosis in 2020, based on the results of a single positive Phase III trial.

Neurology Clinical Trials

Pimavanserin Fails In ENHANCE But Other CNS Uses Targeted

Acadia halts evaluation of pimavanserin as a schizophrenia adjunct but continues study of effect on negative symptoms and in other CNS conditions.


Clinical Trials Research & Development

Acadia, Neuren Headed To Phase III With Trofinetide In Rett Syndrome

Positive Phase II data in the unmet medical need could mean patients will have a therapy specific to their disease, rather than burdensome symptom-by-symptom treatment.

Clinical Trials Rare Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Acadia Pharmaceuticals Inc.
  • Senior Management
  • Stephen Davis, CEO
    Elena Ridloff, EVP, CFO
    Michael J Yang, EVP, Chief Commercial Officer
    Serge Stankovic, MD, Pres.
    Daryl DeKarske, SVP, Global Head, Reg. Affairs
    Charmaine Lykins, SVP, Mktg.
    Bob Mischler, SVP, Strategy & Tech. Operations
    Eliseo Salinas, MD, MSc, SVP, CSO & Head, External Innovation
  • Contact Info
  • Acadia Pharmaceuticals Inc.
    Phone: (858) 558-2871
    3611 Valley Centre Dr.
    Ste. 300
    San Diego, CA 92130